首页> 外文OA文献 >PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)

【2h】

PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)

机译：PIH5系统评价比较5-α还原酶抑制剂（5-Aris）度他雄胺和非那雄胺在良性前列腺增生（BPH）中的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Conte T.; Truzzi J.C.; Tannus G.; Fonseca M.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: Finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride [J] . KaplanS.A., ChungD.E., LeeR.K., International journal of clinical practice . 2012,第11期

机译：对男性前列腺增生症中5α-还原酶抑制剂的5年回顾性分析：非那雄胺的尿毒症功效和前列腺体积减少可比，但与杜他雄胺相比，性副作用和乳腺并发症少
2. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: Finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride [J] . KaplanS.A., ChungD.E., LeeR.K., International journal of clinical practice . 2012,第11期

机译：良性前列腺增生中5α-还原酶抑制剂的次要回顾性分析：美亚甾胺具有相当的泌尿症状疗效和前列腺体积减少，但性副作用较小和乳房并发症比荷兰特德
3. Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis [J] . Cindolo Luca, Alvarez-Maestro Mario, Castellucci Roberto, World journal of urology . 2015,第3期

机译：度他雄胺治疗有症状的前列腺增生症（BPH）的疗效和安全性：系统评价和荟萃分析
4. New Surgical Treatment Options in Patients with Benign Prostate Hyperplasia (BPH) [C] . Werner T.W. de Riese, Thomas Nelius, David R. Aronoff, Conference on lasers in surgery: Advanced characterization, therapeutics, and systems . 2003

机译：良性前列腺增生（BPH）患者的新手术治疗方案
5. The long-term cost-effectiveness of treatments for benign prostatic hyperplasia. [D] . DiSantostefano, Rachael Lynn. 2005

机译：良性前列腺增生治疗的长期成本效益。
6. 5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis [O] . Jennifer E J Jun, Angus Kinkade, Anthony C H Tung, 2017

机译：5α-还原酶抑制剂治疗良性前列腺增生的系统评价和荟萃分析
7. Efficacy and tolerability of the dual 5α-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men [O] . C G Roehrborn, P Ray 2006

机译：双5α-还原酶抑制剂，荷兰特德，在非洲裔美国男子良性前列腺增生中的疗效和耐受性

PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)

著录项

相似文献

相关主题

期刊订阅